Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chih-Lang Lin

Showing results (51-60 of 105) with videos related to

Pageof 11
Sort By:
Hepatology International|August 9, 2018
Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot studyMing-Wei Lai, Chao-Wei Hsu, Chih-Lang Lin, et al.
Journal of Gastroenterology and Hepatology|November 5, 2024
Evolution of hepatitis B virus polymerase and surface genes in patients receiving finite antiviral therapyYu-De Chu, Chao-Wei Hsu, Pei-Huan Ho, et al.
Asian Journal of Surgery|November 11, 2015
Prognosis of papillary thyroid cancers with positive serum thyroglobulin antibody after total thyroidectomySheng-Fong Kuo, Tzu-Chieh Chao, Hung-Yu Chang, et al.
Journal of Cancer|November 19, 2019
The Defective Allele of <i>Aldehyde Dehydrogenase 2</i> Gene is Associated with Favorable Postoperative Prognosis in Hepatocellular CarcinomaPo-Han Huang, Ching-Chih Hu, Cheng-Hung Chien, et al.
Therapeutics and Clinical Risk Management|May 12, 2018
Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapyChing-Chih Hu, Cheng-Hao Weng, Liang-Che Chang, et al.
Renal Failure|January 24, 2012
Predictors of changes in hemoglobin levels in patients with chronic hepatitis C treated with ribavirin plus pegylated interferon-αChing-Chih Hu, Cheng-Hao Weng, Chih-Lang Lin, et al.
Hepatology International|January 4, 2022
GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trialWei-Ting Chen, Shi-Ming Lin, Wei-Chen Lee, et al.
Obesity Science & Practice|February 15, 2023
Waist-to-height ratio for the prediction of gallstone disease among different obesity indicatorsTien-Shin Chou, Chih-Lang Lin, Li-Wei Chen, et al.
Microorganisms|July 27, 2024
The Challenge of a Recall Program from a Community-Based Hepatitis C Screening Campaign: The Effectiveness in HCV MicroeliminationCheng-Hung Chien, Tien-Shin Chou, Li-Wei Chen, et al.
BMC Cancer|March 22, 2019
Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?Ming-Wei Lai, Yu-De Chu, Chih-Lang Lin, et al.
Pageof 11

Showing results (51-60 of 105) with videos related to

Sort By:
Pageof 11
Hepatology International|August 9, 2018
Multiple doses of hepatitis B recombinant vaccine for chronic hepatitis B patients with low surface antigen levels: a pilot studyMing-Wei Lai, Chao-Wei Hsu, Chih-Lang Lin, et al.
Journal of Gastroenterology and Hepatology|November 5, 2024
Evolution of hepatitis B virus polymerase and surface genes in patients receiving finite antiviral therapyYu-De Chu, Chao-Wei Hsu, Pei-Huan Ho, et al.
Asian Journal of Surgery|November 11, 2015
Prognosis of papillary thyroid cancers with positive serum thyroglobulin antibody after total thyroidectomySheng-Fong Kuo, Tzu-Chieh Chao, Hung-Yu Chang, et al.
Journal of Cancer|November 19, 2019
The Defective Allele of <i>Aldehyde Dehydrogenase 2</i> Gene is Associated with Favorable Postoperative Prognosis in Hepatocellular CarcinomaPo-Han Huang, Ching-Chih Hu, Cheng-Hung Chien, et al.
Therapeutics and Clinical Risk Management|May 12, 2018
Simple score to predict risk of hepatocellular carcinoma in chronic hepatitis C patients with advanced fibrosis after pegylated interferon and ribavirin therapyChing-Chih Hu, Cheng-Hao Weng, Liang-Che Chang, et al.
Renal Failure|January 24, 2012
Predictors of changes in hemoglobin levels in patients with chronic hepatitis C treated with ribavirin plus pegylated interferon-αChing-Chih Hu, Cheng-Hao Weng, Chih-Lang Lin, et al.
Hepatology International|January 4, 2022
GALNT14 genotype-guided chemoembolization plus sorafenib therapy in hepatocellular carcinoma: a randomized trialWei-Ting Chen, Shi-Ming Lin, Wei-Chen Lee, et al.
Obesity Science & Practice|February 15, 2023
Waist-to-height ratio for the prediction of gallstone disease among different obesity indicatorsTien-Shin Chou, Chih-Lang Lin, Li-Wei Chen, et al.
Microorganisms|July 27, 2024
The Challenge of a Recall Program from a Community-Based Hepatitis C Screening Campaign: The Effectiveness in HCV MicroeliminationCheng-Hung Chien, Tien-Shin Chou, Li-Wei Chen, et al.
BMC Cancer|March 22, 2019
Is there a sex difference in postoperative prognosis of hepatocellular carcinoma?Ming-Wei Lai, Yu-De Chu, Chih-Lang Lin, et al.
Pageof 11